ID   AK1BA_HUMAN             Reviewed;         316 AA.
AC   O60218; A4D1P1; O75890; Q6FHF3; Q8IWZ1;
DT   10-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   08-FEB-2011, sequence version 2.
DT   10-MAY-2017, entry version 156.
DE   RecName: Full=Aldo-keto reductase family 1 member B10;
DE            EC=1.1.1.-;
DE   AltName: Full=ARL-1;
DE   AltName: Full=Aldose reductase-like;
DE   AltName: Full=Aldose reductase-related protein;
DE            Short=ARP;
DE            Short=hARP;
DE   AltName: Full=Small intestine reductase;
DE            Short=SI reductase;
GN   Name=AKR1B10; Synonyms=AKR1B11;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ASP-313.
RC   TISSUE=Liver tumor;
RX   PubMed=9565553; DOI=10.1074/jbc.273.19.11429;
RA   Cao D., Fan S.T., Chung S.S.M.;
RT   "Identification and characterization of a novel human aldose
RT   reductase-like gene.";
RL   J. Biol. Chem. 273:11429-11435(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Small intestine;
RX   PubMed=9765596; DOI=10.1016/S0167-4781(98)00109-2;
RA   Hyndman D.J., Flynn T.G.;
RT   "Sequence and expression levels in human tissues of a new member of
RT   the aldo-keto reductase family.";
RL   Biochim. Biophys. Acta 1399:198-202(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ASP-313.
RA   Heringlake S.;
RT   "Representational difference analysis based identification and full-
RT   length sequencing of a gene of the aldo-ketoreductase family strongly
RT   overexpressed in hepatocellular carcinoma.";
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ASP-313.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ASP-313.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ASP-313.
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 232-316, AND VARIANT ASP-313.
RX   PubMed=9537432; DOI=10.1002/hep.510270408;
RA   Scuric Z., Stain S.C., Anderson W.F., Hwang J.-J.;
RT   "New member of aldose reductase family proteins overexpressed in human
RT   hepatocellular carcinoma.";
RL   Hepatology 27:943-950(1998).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-125 AND LYS-263, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [12]
RP   SUBCELLULAR LOCATION.
RX   PubMed=21585341; DOI=10.1042/BJ20110111;
RA   Luo D.X., Huang M.C., Ma J., Gao Z., Liao D.F., Cao D.;
RT   "Aldo-keto reductase family 1, member B10 is secreted through a
RT   lysosome-mediated non-classical pathway.";
RL   Biochem. J. 438:71-80(2011).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.25 ANGSTROMS) IN COMPLEX WITH TOLRESTAT AND
RP   NADP, FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, ENZYME REGULATION, AND
RP   MUTAGENESIS OF LYS-125 AND VAL-301.
RX   PubMed=18087047; DOI=10.1073/pnas.0705659105;
RA   Gallego O., Ruiz F.X., Ardevol A., Dominguez M., Alvarez R.,
RA   de Lera A.R., Rovira C., Farres J., Fita I., Pares X.;
RT   "Structural basis for the high all-trans-retinaldehyde reductase
RT   activity of the tumor marker AKR1B10.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:20764-20769(2007).
RN   [14]
RP   VARIANT [LARGE SCALE ANALYSIS] ASP-313, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Acts as all-trans-retinaldehyde reductase. Can
CC       efficiently reduce aliphatic and aromatic aldehydes, and is less
CC       active on hexoses (in vitro). May be responsible for
CC       detoxification of reactive aldehydes in the digested food before
CC       the nutrients are passed on to other organs.
CC       {ECO:0000269|PubMed:18087047}.
CC   -!- ENZYME REGULATION: Inhibited by tolrestat.
CC       {ECO:0000269|PubMed:18087047}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=600 uM for D,L-glyceraldehyde {ECO:0000269|PubMed:18087047};
CC         KM=0.6 uM for all-trans-retinaldehyde
CC         {ECO:0000269|PubMed:18087047};
CC         KM=0.7 uM for 9-cis-retinaldehyde {ECO:0000269|PubMed:18087047};
CC   -!- INTERACTION:
CC       Q13085:ACACA; NbExp=4; IntAct=EBI-1572139, EBI-717681;
CC       Q9NYB0:TERF2IP; NbExp=2; IntAct=EBI-1572139, EBI-750109;
CC   -!- SUBCELLULAR LOCATION: Lysosome {ECO:0000269|PubMed:21585341}.
CC       Secreted {ECO:0000269|PubMed:21585341}. Note=Secreted through a
CC       lysosome-mediated non-classical pathway.
CC   -!- TISSUE SPECIFICITY: Found in many tissues. Highly expressed in
CC       small intestine, colon and adrenal gland.
CC   -!- SIMILARITY: Belongs to the aldo/keto reductase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U37100; AAC17469.1; -; mRNA.
DR   EMBL; AF052577; AAC36465.1; -; mRNA.
DR   EMBL; AF524864; AAO13380.1; -; mRNA.
DR   EMBL; BT006794; AAP35440.1; -; mRNA.
DR   EMBL; CR541801; CAG46600.1; -; mRNA.
DR   EMBL; AC078847; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH236950; EAL24069.1; -; Genomic_DNA.
DR   EMBL; CH471070; EAW83816.1; -; Genomic_DNA.
DR   EMBL; BC008837; AAH08837.1; -; mRNA.
DR   EMBL; AF044961; AAC15671.1; -; mRNA.
DR   CCDS; CCDS5832.1; -.
DR   RefSeq; NP_064695.3; NM_020299.4.
DR   UniGene; Hs.116724; -.
DR   PDB; 1ZUA; X-ray; 1.25 A; X=1-316.
DR   PDB; 4GA8; X-ray; 1.94 A; A=1-316.
DR   PDB; 4GAB; X-ray; 1.60 A; A=1-316.
DR   PDB; 4GQ0; X-ray; 2.10 A; A=1-316.
DR   PDB; 4GQG; X-ray; 1.92 A; A=1-316.
DR   PDB; 4I5X; X-ray; 2.10 A; A=1-316.
DR   PDB; 4ICC; X-ray; 1.75 A; X=1-316.
DR   PDB; 4JIH; X-ray; 2.30 A; A=1-316.
DR   PDB; 4JII; X-ray; 2.20 A; X=1-316.
DR   PDB; 4WEV; X-ray; 1.45 A; X=1-316.
DR   PDB; 4XZL; X-ray; 1.70 A; X=1-316.
DR   PDB; 4XZM; X-ray; 1.75 A; X=1-316.
DR   PDB; 4XZN; X-ray; 1.70 A; X=1-316.
DR   PDB; 5LIK; X-ray; 2.05 A; X=1-316.
DR   PDB; 5LIU; X-ray; 1.75 A; X=1-316.
DR   PDB; 5LIW; X-ray; 1.75 A; X=1-316.
DR   PDB; 5LIX; X-ray; 1.95 A; X=1-316.
DR   PDB; 5LIY; X-ray; 2.05 A; X=1-316.
DR   PDB; 5M2F; X-ray; 1.50 A; X=1-316.
DR   PDBsum; 1ZUA; -.
DR   PDBsum; 4GA8; -.
DR   PDBsum; 4GAB; -.
DR   PDBsum; 4GQ0; -.
DR   PDBsum; 4GQG; -.
DR   PDBsum; 4I5X; -.
DR   PDBsum; 4ICC; -.
DR   PDBsum; 4JIH; -.
DR   PDBsum; 4JII; -.
DR   PDBsum; 4WEV; -.
DR   PDBsum; 4XZL; -.
DR   PDBsum; 4XZM; -.
DR   PDBsum; 4XZN; -.
DR   PDBsum; 5LIK; -.
DR   PDBsum; 5LIU; -.
DR   PDBsum; 5LIW; -.
DR   PDBsum; 5LIX; -.
DR   PDBsum; 5LIY; -.
DR   PDBsum; 5M2F; -.
DR   ProteinModelPortal; O60218; -.
DR   SMR; O60218; -.
DR   BioGrid; 121325; 18.
DR   IntAct; O60218; 6.
DR   STRING; 9606.ENSP00000352584; -.
DR   BindingDB; O60218; -.
DR   ChEMBL; CHEMBL5983; -.
DR   DrugBank; DB03461; 2'-Monophosphoadenosine 5'-Diphosphoribose.
DR   DrugBank; DB02383; Tolrestat.
DR   iPTMnet; O60218; -.
DR   PhosphoSitePlus; O60218; -.
DR   BioMuta; AKR1B10; -.
DR   DOSAC-COBS-2DPAGE; O60218; -.
DR   EPD; O60218; -.
DR   MaxQB; O60218; -.
DR   PaxDb; O60218; -.
DR   PeptideAtlas; O60218; -.
DR   PRIDE; O60218; -.
DR   DNASU; 57016; -.
DR   Ensembl; ENST00000359579; ENSP00000352584; ENSG00000198074.
DR   GeneID; 57016; -.
DR   KEGG; hsa:57016; -.
DR   UCSC; uc003vrr.4; human.
DR   CTD; 57016; -.
DR   DisGeNET; 57016; -.
DR   GeneCards; AKR1B10; -.
DR   H-InvDB; HIX0007102; -.
DR   H-InvDB; HIX0033661; -.
DR   HGNC; HGNC:382; AKR1B10.
DR   HPA; CAB070163; -.
DR   HPA; HPA020280; -.
DR   HPA; HPA073633; -.
DR   MIM; 604707; gene.
DR   neXtProt; NX_O60218; -.
DR   OpenTargets; ENSG00000198074; -.
DR   PharmGKB; PA24676; -.
DR   eggNOG; KOG1577; Eukaryota.
DR   eggNOG; COG0656; LUCA.
DR   GeneTree; ENSGT00760000119041; -.
DR   HOGENOM; HOG000250272; -.
DR   HOVERGEN; HBG000020; -.
DR   InParanoid; O60218; -.
DR   KO; K00011; -.
DR   OMA; VSNFSHF; -.
DR   OrthoDB; EOG091G0D69; -.
DR   PhylomeDB; O60218; -.
DR   TreeFam; TF106492; -.
DR   BRENDA; 1.1.1.21; 2681.
DR   Reactome; R-HSA-975634; Retinoid metabolism and transport.
DR   SABIO-RK; O60218; -.
DR   EvolutionaryTrace; O60218; -.
DR   GeneWiki; AKR1B10; -.
DR   GenomeRNAi; 57016; -.
DR   PRO; PR:O60218; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000198074; -.
DR   CleanEx; HS_AKR1B10; -.
DR   Genevisible; O60218; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005764; C:lysosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0004033; F:aldo-keto reductase (NADP) activity; TAS:UniProtKB.
DR   GO; GO:0045550; F:geranylgeranyl reductase activity; IDA:UniProtKB.
DR   GO; GO:0047718; F:indanol dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0001758; F:retinal dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0006081; P:cellular aldehyde metabolic process; TAS:ProtInc.
DR   GO; GO:0044597; P:daunorubicin metabolic process; IMP:UniProtKB.
DR   GO; GO:0007586; P:digestion; TAS:ProtInc.
DR   GO; GO:0044598; P:doxorubicin metabolic process; IMP:UniProtKB.
DR   GO; GO:0016488; P:farnesol catabolic process; IDA:UniProtKB.
DR   GO; GO:0001523; P:retinoid metabolic process; TAS:Reactome.
DR   GO; GO:0008202; P:steroid metabolic process; TAS:ProtInc.
DR   CDD; cd06660; Aldo_ket_red; 1.
DR   Gene3D; 3.20.20.100; -; 1.
DR   InterPro; IPR018170; Aldo/ket_reductase_CS.
DR   InterPro; IPR020471; Aldo/keto_reductase.
DR   InterPro; IPR023210; NADP_OxRdtase_dom.
DR   PANTHER; PTHR11732; PTHR11732; 1.
DR   Pfam; PF00248; Aldo_ket_red; 1.
DR   PIRSF; PIRSF000097; AKR; 1.
DR   PRINTS; PR00069; ALDKETRDTASE.
DR   SUPFAM; SSF51430; SSF51430; 1.
DR   PROSITE; PS00798; ALDOKETO_REDUCTASE_1; 1.
DR   PROSITE; PS00062; ALDOKETO_REDUCTASE_2; 1.
DR   PROSITE; PS00063; ALDOKETO_REDUCTASE_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Lysosome; NADP;
KW   Oxidoreductase; Polymorphism; Reference proteome; Secreted.
FT   CHAIN         1    316       Aldo-keto reductase family 1 member B10.
FT                                /FTId=PRO_0000124632.
FT   NP_BIND      20     22       NADP. {ECO:0000269|PubMed:18087047}.
FT   NP_BIND     160    161       NADP. {ECO:0000269|PubMed:18087047}.
FT   NP_BIND     210    217       NADP. {ECO:0000269|PubMed:18087047}.
FT   NP_BIND     261    273       NADP. {ECO:0000269|PubMed:18087047}.
FT   ACT_SITE     49     49       Proton donor.
FT                                {ECO:0000269|PubMed:18087047}.
FT   BINDING      44     44       NADP. {ECO:0000269|PubMed:18087047}.
FT   BINDING     111    111       Substrate. {ECO:0000269|PubMed:18087047}.
FT   BINDING     184    184       NADP. {ECO:0000269|PubMed:18087047}.
FT   SITE         78     78       Lowers pKa of active site Tyr.
FT                                {ECO:0000250|UniProtKB:P14550}.
FT   MOD_RES     125    125       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     263    263       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VARIANT      87     87       P -> S (in dbSNP:rs2303312).
FT                                /FTId=VAR_020077.
FT   VARIANT     286    286       M -> T (in dbSNP:rs3735042).
FT                                /FTId=VAR_020078.
FT   VARIANT     313    313       N -> D (in dbSNP:rs4728329).
FT                                {ECO:0000244|PubMed:21269460,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9537432,
FT                                ECO:0000269|PubMed:9565553,
FT                                ECO:0000269|Ref.3, ECO:0000269|Ref.4,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_013287.
FT   MUTAGEN     125    125       K->L: Increased affinity and reduced
FT                                catalytic activity towards all-trans-
FT                                retinaldehyde.
FT                                {ECO:0000269|PubMed:18087047}.
FT   MUTAGEN     301    301       V->L: Reduced catalytic activity towards
FT                                all-trans-retinaldehyde.
FT                                {ECO:0000269|PubMed:18087047}.
FT   CONFLICT     76     76       V -> A (in Ref. 3; AAO13380).
FT                                {ECO:0000305}.
FT   CONFLICT    100    100       L -> P (in Ref. 3; AAO13380).
FT                                {ECO:0000305}.
FT   CONFLICT    288    288       T -> I (in Ref. 3; AAO13380).
FT                                {ECO:0000305}.
FT   STRAND        4      6       {ECO:0000244|PDB:1ZUA}.
FT   STRAND       12     19       {ECO:0000244|PDB:1ZUA}.
FT   TURN         25     27       {ECO:0000244|PDB:1ZUA}.
FT   HELIX        28     37       {ECO:0000244|PDB:1ZUA}.
FT   STRAND       42     44       {ECO:0000244|PDB:1ZUA}.
FT   HELIX        47     49       {ECO:0000244|PDB:1ZUA}.
FT   HELIX        52     64       {ECO:0000244|PDB:1ZUA}.
FT   HELIX        70     72       {ECO:0000244|PDB:1ZUA}.
FT   STRAND       74     79       {ECO:0000244|PDB:1ZUA}.
FT   HELIX        81     83       {ECO:0000244|PDB:4WEV}.
FT   HELIX        86    100       {ECO:0000244|PDB:1ZUA}.
FT   STRAND      105    111       {ECO:0000244|PDB:1ZUA}.
FT   STRAND      118    120       {ECO:0000244|PDB:4WEV}.
FT   STRAND      127    131       {ECO:0000244|PDB:1ZUA}.
FT   HELIX       138    150       {ECO:0000244|PDB:1ZUA}.
FT   STRAND      153    161       {ECO:0000244|PDB:1ZUA}.
FT   HELIX       164    171       {ECO:0000244|PDB:1ZUA}.
FT   STRAND      181    186       {ECO:0000244|PDB:1ZUA}.
FT   HELIX       194    202       {ECO:0000244|PDB:1ZUA}.
FT   STRAND      206    211       {ECO:0000244|PDB:1ZUA}.
FT   HELIX       228    230       {ECO:0000244|PDB:1ZUA}.
FT   HELIX       232    240       {ECO:0000244|PDB:1ZUA}.
FT   HELIX       245    254       {ECO:0000244|PDB:1ZUA}.
FT   TURN        255    257       {ECO:0000244|PDB:1ZUA}.
FT   HELIX       267    274       {ECO:0000244|PDB:1ZUA}.
FT   HELIX       283    290       {ECO:0000244|PDB:1ZUA}.
FT   HELIX       302    304       {ECO:0000244|PDB:1ZUA}.
FT   STRAND      305    307       {ECO:0000244|PDB:4GAB}.
FT   HELIX       311    313       {ECO:0000244|PDB:4GAB}.
SQ   SEQUENCE   316 AA;  36020 MW;  0C2FC0E798955A33 CRC64;
     MATFVELSTK AKMPIVGLGT WKSPLGKVKE AVKVAIDAGY RHIDCAYVYQ NEHEVGEAIQ
     EKIQEKAVKR EDLFIVSKLW PTFFERPLVR KAFEKTLKDL KLSYLDVYLI HWPQGFKSGD
     DLFPKDDKGN AIGGKATFLD AWEAMEELVD EGLVKALGVS NFSHFQIEKL LNKPGLKYKP
     VTNQVECHPY LTQEKLIQYC HSKGITVTAY SPLGSPDRPW AKPEDPSLLE DPKIKEIAAK
     HKKTAAQVLI RFHIQRNVIV IPKSVTPARI VENIQVFDFK LSDEEMATIL SFNRNWRACN
     VLQSSHLEDY PFNAEY
//
